161 related articles for article (PubMed ID: 34638302)
1. Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell Regulation.
Nathansen J; Meyer F; Müller L; Schmitz M; Borgmann K; Dubrovska A
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638302
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathology underlying the robustness of cancer stem cells.
Yoshida GJ; Saya H
Regen Ther; 2021 Jun; 17():38-50. PubMed ID: 33869685
[TBL] [Abstract][Full Text] [Related]
3. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
5. Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells.
Wang Y; Xu H; Liu T; Huang M; Butter PP; Li C; Zhang L; Kao GD; Gong Y; Maity A; Koumenis C; Fan Y
JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415883
[TBL] [Abstract][Full Text] [Related]
6. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
[TBL] [Abstract][Full Text] [Related]
7. Implications of cancer stem cells in developing therapeutic resistance in oral cancer.
Naik PP; Das DN; Panda PK; Mukhopadhyay S; Sinha N; Praharaj PP; Agarwal R; Bhutia SK
Oral Oncol; 2016 Nov; 62():122-135. PubMed ID: 27865365
[TBL] [Abstract][Full Text] [Related]
8. Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage.
Park SY; Kim JY; Jun Y; Nam JS
Recent Pat Anticancer Drug Discov; 2018; 13(1):18-39. PubMed ID: 28971778
[TBL] [Abstract][Full Text] [Related]
9. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
10. Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.
Chanmee T; Ontong P; Kimata K; Itano N
Front Oncol; 2015; 5():180. PubMed ID: 26322272
[TBL] [Abstract][Full Text] [Related]
11. DNA Double Strand Break Repair - Related Synthetic Lethality.
Toma M; Skorski T; Sliwinski T
Curr Med Chem; 2019; 26(8):1446-1482. PubMed ID: 29421999
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
Jayachandran A; Dhungel B; Steel JC
J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
[TBL] [Abstract][Full Text] [Related]
13. The replicative senescent mesenchymal stem / stromal cells defect in DNA damage response and anti-oxidative capacity.
Yu J; Shi J; Zhang Y; Zhang Y; Huang Y; Chen Z; Yang J
Int J Med Sci; 2018; 15(8):771-781. PubMed ID: 30008586
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance.
Tuy K; Rickenbacker L; Hjelmeland AB
Redox Biol; 2021 Aug; 44():101953. PubMed ID: 34052208
[TBL] [Abstract][Full Text] [Related]
15. Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
Doherty MR; Cheon H; Junk DJ; Vinayak S; Varadan V; Telli ML; Ford JM; Stark GR; Jackson MW
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13792-13797. PubMed ID: 29229854
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
17. DNA damage and repair in differentiation of stem cells and cells of connective cell lineages: A trigger or a complication?
Sjakste N; Riekstiņa U
Eur J Histochem; 2021 May; 65(2):. PubMed ID: 33942598
[TBL] [Abstract][Full Text] [Related]
18. Regulation of breast cancer stem cell features.
Czerwinska P; Kaminska B
Contemp Oncol (Pozn); 2015; 19(1A):A7-A15. PubMed ID: 25691826
[TBL] [Abstract][Full Text] [Related]
19. A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling.
Bocci F; Jolly MK; George JT; Levine H; Onuchic JN
Oncotarget; 2018 Jul; 9(52):29906-29920. PubMed ID: 30042822
[TBL] [Abstract][Full Text] [Related]
20. The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.
Pustovalova M; Alhaddad L; Blokhina T; Smetanina N; Chigasova A; Chuprov-Netochin R; Eremin P; Gilmutdinova I; Osipov AN; Leonov S
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
